Supplier
Lincare Pharmacy Services INC.
Lincare Pharmacy Services INC. was paid $2.90M by Medicaid between Jan 2018 and Dec 2024, across 17 billing codes. Its largest line is J7606, Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms — 25% of everything it billed.
33Billing provider infoLINCARE PHARMACY SERVICES INC.
KANSAS CITY, MO 64116
KANSAS CITY, MO 64116
33aNPI1134698418assigned 11/16/2018
33bProvider typeCommunity/Retail Pharmacy
28Total paid$2.90M
24GClaims584,692
24DCodes billed17
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community/Retail Pharmacy providers in Missouri
Rank by total paid#3 of 47
Median peer was paid$3K
This provider vs. median993×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BARNHARD, JEFFREY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,474 | $77K | |
| 2019 | 95,660 | $237K | |
| 2020 | 120,242 | $447K | |
| 2021 | 141,646 | $739K | |
| 2022 | 105,036 | $695K | |
| 2023 | 76,083 | $493K | |
| 2024incomplete | 32,551 | $216K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms | 25% | 13,325 | 10,730 | $716K |
| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms | 19% | 13,431 | 10,799 | $565K |
| J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram | 17% | 10,460 | 4,037 | $506K |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | 14% | 130,534 | 111,409 | $394K |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | 7.9% | 27,825 | 22,688 | $228K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 5.5% | 100,759 | 83,995 | $159K |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 4.4% | 61,115 | 50,538 | $127K |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | 2.1% | 30,008 | 27,584 | $62K |
| E0570 | Nebulizer, with compressor | 1.6% | 48,570 | 45,074 | $46K |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | 1.3% | 79,623 | 69,375 | $39K |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 17,936 | 14,822 | $24K |
| Q0514 | Pharmacy dispensing fee for inhalation drug(s); per 90 days | <1% | 1,248 | 1,152 | $10K |
5 more codes
| G0333 | Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary | <1% | 2,807 | $10K |
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | <1% | 120 | $9K |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 35,512 | $6K |
| A7013 | Filter, disposable, used with aerosol compressor or ultrasonic generator | <1% | 8,797 | $1K |
| A7014 | Filter, nondisposable, used with aerosol compressor or ultrasonic generator | <1% | 2,622 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARNHARD, JEFFREY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Founders Healthcare, LLC | Phoenix, AZ | $66.75M |
| Founders Healthcare, LLC | Tucson, AZ | $20.76M |
| Founders Healthcare, LLC | Las Vegas, NV | $18.86M |
| Lincare INC. | Greenwood, IN | $16.16M |
| Lincare INC. | Fort Wayne, IN | $13.95M |
| Lincare INC | Westerville, OH | $12.98M |
| Patient Support Services, INC | Texarkana, TX | $10.33M |
| Founders Healthcare, LLC | Glendale, AZ | $8.92M |
| Founders Healthcare LLC | Tempe, AZ | $7.47M |
| RCS Management Corp | Surprise, AZ | $5.55M |
| Lincare INC. | South Point, OH | $4.86M |
| Lincare INC | Moraine, OH | $4.56M |
| Lincare INC. | Asheville, NC | $4.35M |
| Lincare INC. | Cincinnati, OH | $4.34M |
| Lincare INC | Terre Haute, IN | $4.31M |
| Lincare INC | Bridgeport, WV | $3.97M |
| Lincare INC. | Madison, IN | $3.66M |
| Lincare INC. | Winston-salem, NC | $3.55M |
| Lincare INC. | Largo, FL | $3.08M |
| Lincare INC. | Concord, CA | $2.75M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.